AG真人官方

8x8, Inc. (EGHT) 鈥� Form 4 filing: Director Todd R. Ford received 66,502 restricted stock units (RSUs) on 07/25/2025. The award has a $0 purchase price and will vest and settle in common shares on the earlier of 25 Jul 2026 or the next annual shareholder meeting, provided Ford remains in service. After this grant, Ford鈥檚 direct beneficial ownership increases to 250,609 shares.

No shares were sold, and no derivative securities were exercised or disposed of. Because the grant is part of routine board compensation, the cash impact to Ford and the company is minimal, but the filing does marginally increase insider equity alignment. The document contains no operational, earnings or guidance information.

Q2 FY25 snapshot: Net sales rose 10.8% to $235.8 m, propelled by first-time consolidation of Hiya ($33.9 m). Ex-Hiya, direct-selling revenue fell 5.7% on an 8.9% decline in Asia-Pacific active customers and 17.2% drop in Americas/Europe. Gross margin contracted 240 bps to 78.7% as Hiya carries lower margins. SG&A ratio climbed 450 bps to 34.7%, while Brand-Partner incentives eased to 36.9% on mix. Operating income slipped 6% to $16.7 m and diluted EPS decreased 3.7% to $0.52.

Year-to-date: Sales grew 10.1% to $485.4 m, yet EPS fell 28% to $1.01 as operating margin compressed to 6.7% (9.7% LY). Operating cash flow reached $27.7 m, but cash fell $30.4 m to $151.3 m after $27.7 m buybacks and $7.8 m capex; the $23 m credit line was fully repaid, and a new $75 m facility extends to 2030. Inventories increased 19% to $83.3 m. Redeemable NCI for Hiya stands at $54.5 m; equity totals $531.1 m on 18.3 m shares outstanding.

Key takeaways: Organic customer attrition continues鈥攑articularly in China, South Korea and the U.S.鈥攑ressuring legacy volume. Hiya adds growth but dilutes margin and lifts amortization expense. Management expects limited effect from the July 2025 tax bill, yet FX volatility, regulatory risk and customer acquisition costs remain focal concerns.

8x8, Inc. (EGHT) Form 4 filed 08/04/2025 reports that director Monique Bonner was granted 66,502 cash-settled restricted stock units (RSUs) on 07/25/2025. Each unit converts into a cash payment equal to one share鈥檚 market value upon vesting. The entire award vests and settles in cash on the earlier of 25 Jul 2026 or the company鈥檚 next annual shareholder meeting, provided the director remains in service. No common shares were bought or sold, and Bonner鈥檚 post-transaction beneficial holding stands at 66,502 derivative securities; no direct share ownership changes were disclosed. The filing reflects routine board compensation and does not signal any change in the company鈥檚 financial outlook.

Q2-25 headline: Net revenue $150.0 M (+72% YoY) driven by Auvelity, Sunosi and first weeks of Symbravo launch; GAAP net loss narrowed to $48.0 M (-39% YoY) or 鈥�$0.97/sh.

Six-month revenue reached $271.5 M (+67%) while loss trimmed to $107.4 M. Gross margin remained high (cost of revenue 鈮�9% of sales), but SG&A climbed 26% to $130.3 M as Axsome expanded its commercial footprint. R&D held steady at $49.5 M with multiple late-stage CNS programs in progress.

Cash & equivalents closed at $303.0 M; operating cash burn fell to $75.8 M. In May the company refinanced via a new $570 M facility with Blackstone: $120 M term loan and $70 M revolver drawn, retiring the costlier Hercules loan and expected to lower interest expense; Blackstone also invested $15 M in common stock. Total debt now $188 M, shareholders鈥� equity $73 M.

FDA approved migraine therapy Symbravo in Jan-25 with U.S. launch in June, giving Axsome three commercial products. Management believes current liquidity funds operations for at least 12 months. Key risks are sustained commercial uptake, sizable rebates/discounts ($118 M accrued), and ongoing operating losses.

Kinder Morgan (KMI) Form 4 filing: Vice President Sital K. Mody reported the sale of 45,549 Class P common shares on 1 Aug 2025 at a weighted-average price of $27.961 per share. The disposition was executed under a pre-arranged Rule 10b5-1 trading plan adopted 22 Apr 2024.

Following the transaction, the filing shows 0 shares beneficially owned, indicating that the officer no longer holds KMI common stock directly. No derivative security activity was reported.

The sale represents an estimated cash value of 鈮�$1.27 million (45,549 脳 $27.961). While sales under 10b5-1 reduce timing-signal risk, a complete divestiture by a senior executive can be interpreted as a potential negative sentiment indicator for some investors. However, it does not automatically imply changes to company fundamentals.

GXO Logistics (GXO) Form 3: Newly appointed director Michael Kneeland filed his initial beneficial ownership statement for the event dated 30 Jul 2025.

Mr. Kneeland reports direct ownership of 3,672 GXO common shares and no derivative securities. The filing is made solely on his behalf; he is classified as a director, not a 10% owner or officer. No purchases, sales or equity awards are disclosed, and an attached power-of-attorney authorizes the signatory. No other material corporate information accompanies this routine governance filing.

8x8, Inc. (EGHT) 鈥� Form 4 insider filing

On 25 Jul 2025, director John Pagliuca received 66,502 restricted stock units (RSUs) at an exercise price of $0 (transaction code 鈥淎鈥�). The award will vest and settle in cash on the earlier of 25 Jul 2026 or the next annual shareholder meeting, contingent on continued board service. Following the grant, Pagliuca鈥檚 directly held derivative position equals 66,502 RSUs linked to EGHT common shares.

The cash鈥恠ettled design delivers equity-linked upside to the director without issuing new shares, eliminating dilution but creating a future cash outflow equivalent to the share value on the vesting date.

Form 4 filing for 8x8, Inc. (EGHT) discloses that independent director Alison Gleeson received an equity grant on 07/25/2025.

• Grant details: 66,502 restricted stock units (RSUs) awarded at no cost. RSUs vest in full on the earlier of 25 Jul 2026 or the next annual shareholder meeting, contingent on continued board service.
• Post-grant ownership: Gleeson now beneficially owns 230,597 EGHT common shares, held directly.
• Purpose: Routine annual director compensation; no open-market purchase or sale took place.

No derivative securities were reported. The transaction does not affect share count, cash flow, or earnings but modestly increases insider ownership, potentially aligning director incentives with shareholder interests.

Patterson-UTI Energy (PTEN) posted a sharp swing to loss in Q2 25. Revenue fell 10% YoY to $1.22 bn, driven by softer activity in Drilling (-8%) and Completion Services (-11%). Operating results turned from a $45 m profit to a $29 m loss as lower volumes, cost pressure and a $27.8 m impairment on Latin-American drilling assets weighed on margins. Net loss attributable to shareholders was $49.1 m (-$0.13/sh) versus $11.1 m (+$0.03) a year ago.

For 1H 25, revenue declined 13% to $2.50 bn and the company recorded a $47.4 m net loss. Cash flow from operations dropped to $347.9 m (-38%), while capex remained high at $306 m, cutting cash on hand to $185.9 m (31 Dec 24: $241.3 m). Liquidity is supported by an undrawn $500 m unsecured revolver (available $498 m) and no near-term debt maturities after retiring $6.4 m of equipment loans.

Balance-sheet equity slipped 4% to $3.35 bn, largely from losses and $35.8 m of share repurchases (4.28 m shares). PTEN maintained its quarterly dividend at $0.08/sh (payout $30.7 m) and still has $728 m remaining on its $1 bn buyback authorisation.

Segment view: Drilling Services stayed profitable ($40.6 m) but Completion Services swung to a $29.2 m loss; Drilling Products earned $6.8 m. Contract drilling backlog stands at $312 m, with 9% extending beyond 12 months.

Outlook concerns: lower U.S. rig counts, OPEC+ supply increases and macro uncertainty pressured activity; management warns further weakness could trigger additional impairments.